Levetiracetam 250 mg + Levetiracetam 500 mg

ApprovedCompleted
1 views this week 0 watching Active
Interest: 43/100
43
Hype Score

Development Stage

Pre-clinical
Phase 1
Phase 2
Phase 3
5
Approved
Indication / Disease

Healthy Subjects

Conditions

Healthy Subjects, Renal Impairments

Trial Timeline

Nov 1, 2011 → Nov 1, 2012

About Levetiracetam 250 mg + Levetiracetam 500 mg

Levetiracetam 250 mg + Levetiracetam 500 mg is a approved stage product being developed by UCB for Healthy Subjects. The current trial status is completed. This product is registered under clinical trial identifier NCT01491113. Target conditions include Healthy Subjects, Renal Impairments.

What happened to similar drugs?

20 of 20 similar drugs in Healthy Subjects were approved

Approved (20) Terminated (1) Active (0)

Hype Score Breakdown

Clinical
20
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (2)

NCT IDPhaseStatus
NCT01491113ApprovedCompleted
NCT00280696Phase 3Completed

Competing Products

20 competing products in Healthy Subjects

See all competitors
ProductCompanyStageHype Score
Use of Wearable Digital Sensors After mRNA Vaccination in AdultsModernaPreclinical
0
mRNA-0184ModernaPhase 1
0
mRNA-6231ModernaPhase 1
0
LetrozoleDr. Reddy's LaboratoriesPhase 1
26
IsotretinoinDr. Reddy's LaboratoriesPhase 1
26
FexofenadineDr. Reddy's LaboratoriesPhase 1
26
SertralineDr. Reddy's LaboratoriesPhase 1
26
Nizatidine + AxidDr. Reddy's LaboratoriesPhase 1
26
AnastrozoleDr. Reddy's LaboratoriesPhase 1
26
mRNA-1273.712ModernaApproved
0
RisperidoneDr. Reddy's LaboratoriesPhase 1
26
LamotrigineDr. Reddy's LaboratoriesPhase 1
26
Metformin + GlucophageDr. Reddy's LaboratoriesPhase 1
26
LamotrigineDr. Reddy's LaboratoriesPhase 1
26
mRNA-0184ModernaPhase 1
0
Divalproex SodiumDr. Reddy's LaboratoriesPhase 1
26
SirolimusDr. Reddy's LaboratoriesPhase 1
26
GlimepirideDr. Reddy's LaboratoriesPhase 1
26
Ziprasidone HydrochlorideDr. Reddy's LaboratoriesPhase 1
26
Naproxen sodiumDr. Reddy's LaboratoriesPhase 1
26